News
-
Sexual misconduct on record
Wednesday | Dec 17 2025THE Australian Health Practitioner Regulation Agency (Ahpra) and National Boards have announced changes to the way sexual misconduct is reported on the public register of practitioners, commencing early next year.
-
Ross River virus mosquito warning
Wednesday | Dec 17 2025HOLIDAY makers are being urged to stay vigilant against mosquito bites this summer, as warmer temperatures heighten the risk of Ross River virus outbreaks, especially in riverland and coastal regions.
-
Arriving today
Wednesday | Dec 17 2025CHECK your inbox for the PD Year in Review, featuring exclusive interviews with pharmacy leaders and a wrap of 2025's biggest news.
-
Mayne opens new facility
Wednesday | Dec 17 2025MAYNE Pharma officially opened a newly expanded manufacturing facility yesterday in Salisbury, South Australia, attended by SA Minister for Trade and Investment Joe Szakacs and other dignitaries.
-
CAR T-cell therapy service for SA
Wednesday | Dec 17 2025THE South Australian government has announced it will establish a dedicated CAR T-cell therapy service as a line of treatment for people living with blood cancer, marking a major advancement in cancer care in the state.
-
Mag-Sup powder – a better way to absorb magnesium
Wednesday | Dec 17 2025MAG-SUP powder is a high absorption magnesium supplement for use in magnesium deficiencies.
-
Aussie men’s health clinic goes global
Tuesday | Dec 16 2025PIONEERING pharmacist-led men's health initiative, Men's Health Downunder (MHDU), has expanded internationally and is now starting to provide the same expert services in a number of locations across the Republic of Ireland.
-
Nursing’s new voice at AMH
Tuesday | Dec 16 2025IN A move that reflects the expanded scope of practice in nursing, the Australian Medicines Handbook (AMH) has appointed Nurse Practitioner Peter Cirocco (pictured) to its Editorial Advisory Committee, continuing its commitment to the evolving needs of health professionals.
-
New treatments, and first of kind self-test for gonorrhoea
Tuesday | Dec 16 2025THE US Food and Drug Administration (FDA) has approved GSK's Blujepa (gepotidacin) and Innoviva's Nuzolvence (zoliflodacin) for the treatment of uncomplicated urogenital gonorrhoea in adults and adolescents, the first drugs from new antibiotic classes to be approved for the disease in over three decades.
-
Kids’ homeopathy safety recall
Tuesday | Dec 16 2025KEY Sun Laboratories is recalling one batch of Key Sun Kids Travel Sickness Homeopathic Product, due to the risk of a small metal wire being present in the lozenge.
